Australia's largest stock trading and investment forum Australia's #1 stock forum

Seems to be getting much traction in the US, huge news...

First 55 Last

Share
Profile

Follow
dazatoN

8,140 Posts.

483

30/06/20

23:01

Post #: 45552065
Share

Originally posted by dazatoN: ↑

ATH could be the next ESK tomorrow

ATH-The most undervalued Biotech on the ASX
- Just announced today that ithas received guidance from (FDA) in relation to the development pathway for ATH434 (previously PBT434), the company’s lead compound for the treatment of Multiple System Atrophy (MSA), a Parkinsonian disorder.
- The company recently met with the FDA following thesuccessful completion of its Phase 1 clinical trial last year
-No current treatments for Parkinsons
- “The FDA clearly recognizes the seriousness of MSA and the need for new treatments to address this devastating Orphan disease. Our pre-IND meeting was very collegial."
-“Because we’re treating the underlying cause of disease by targeting alpha synuclein, I think we have potential to affect all aspects of disease — the motor symptoms, the blood pressure problems, gait and balance, and even bowel and bladder dysfunction."

- 10.4mill cash, 16mill market cap
- Top 20 hold 88%, extremely tightly held. There are some big names on register who dont care about short term price movements, but rather believe in the science. Worth mentioning that suffering shareholders have been holding ATH for years, they too believe in the science.
-Life Biosciences LLC have invested $12mill at 3.9c last year

Chart says it all, we could get another stellar run in 2013 when it went from 10c to $1.40. Stock has been doing nothing for decades, what a base
Im guessing tomorrow is the beginning of that stellar run.
Currently up 200% on NASDAQ.

Expand

Seems to be getting much traction in the US, huge news coverage

https://www.streetinsider.com/PRNewswire/Alterity+Therapeutics+meeting+with+US+FDA+provides+development+pathway+for+ATH434/17060860.html

https://alphastocknews.com/alterity-therapeutics-athe-stock-rockets-on-fda-news/3666/

Last edited by dazatoN: 30/06/20
6 Upvote

2 Great analysis

Reply

Top Stories

IRX

InhaleRX snags $38.5M in funding from VC biotech funder Clendon

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

MTH

Mithril's drilling in Mexico picks up silver at 997g/t, gold at 28g/t

Week 42 Wrap: HotCopper's top picks; new ASX 200 record; world yawns at war

SNX

Sierra Nevada raises $2M for silver exploration at Blackhawk

What's causing the cost-of-living crisis, and how to navigate it

M4M

Macro, Norden set up transport solutions initiative for West Pilbara

NVU

Nanoveu surges 10% after benchmark testing for new AI chip begins

TLG

Talga Group wins key permit for flagship graphite mine in Sweden

SWP

Swoop lobs $18M offer at microcap telecom Vonex – in which it holds 19.9%